Cemax display stations win FDA nod

Article

PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations,

PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations, two of the products in the Fremont,CA, vendor's Perfect Vision series of display technology.

ClinicalView is a Sun-based display station designed for nurses,physicians and technologists at hospital locations outside theradiology department, such as emergency and critical care units.The workstation has a resolution of 1280 x 1600 on a 24-inch portraitmonitor.

DiagnosticView, also a Sun-based system, is a review stationwith 2000 x 2000-pixel resolution, 21-inch portrait monitors foruse by radiologists. Both workstations support Fuji and Du Pontcomputed radiography devices and interfaces with Lumisys and DuPont digitizers.

The display stations archive to 8-mm digital tape and aresupported by the company's ImageServer distributed image managementand archiving architecture. Cemax received FDA clearance for itsImageServer software last year (SCAN 12/29/93).

Cemax signed a joint sales and marketing agreement with 3Min February for the Perfect Vision products. 3M unveiled the Cemaxline as the 3M Image Management System at last month's AmericanInstitute of Ultrasound in Medicine meeting.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.